 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | LusiNEX (tocilizumab biosimilar) / Gedeon Richter
Journal: ?Description of a new Kurixalus species (Rhacophoridae, Anura) and a northwards range extension of the genus. (Pubmed Central) - Feb 10, 2023
We named the species described here as Kurixalusinexpectatus sp...due to the nature of the discovery, as well as the adjunct distribution of the species relative to its closest congeners. The species was found in Zhejiang Province and it represents a range extension of 663 km for the Kurixalus genus.
- ||| LusiNEX (tocilizumab biosimilar) / Gedeon Richter, Actemra IV (tocilizumab) / Roche, JW Pharma
Trial completion: Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers (clinicaltrials.gov) - Feb 26, 2019
P1, N=190, Completed, Sponsor: Mycenax Biotech Inc.
The species was found in Zhejiang Province and it represents a range extension of 663 km for the Kurixalus genus. Active, not recruiting --> Completed
- | LusiNEX (tocilizumab biosimilar) / Gedeon Richter, Actemra IV (tocilizumab) / Roche, JW Pharma
Enrollment closed: Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers (clinicaltrials.gov) - Nov 5, 2018
P1, N=190, Active, not recruiting, Sponsor: Mycenax Biotech Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | LusiNEX (tocilizumab biosimilar) / Gedeon Richter, Actemra IV (tocilizumab) / Roche, JW Pharma
New P1 trial: Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers (clinicaltrials.gov) - May 11, 2018
P1, N=190, Recruiting, Sponsor: Mycenax Biotech Inc.